Panacea Biotec up 5% as Co begins producing Sputnik V vaccine in India – Business Standard
- Panacea Biotec up 5% as Co begins producing Sputnik V vaccine in India Business Standard
- Sputnik single-shot Covid vaccine undergoing final trials: Russian envoy Mint
- ‘Sputnik V vaccine supplies in accordance to contract,’ says Russia Hindustan Times
- Panacea Biotec share rises 5% on Sputnik V vaccine production in India Business Today
- Panacea Biotec share price hits 5% upper circuit on launch of Sputnik V production Moneycontrol.com
- View Full coverage on Google News